These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23722901)

  • 1. 11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects.
    Tiganescu A; Tahrani AA; Morgan SA; Otranto M; Desmoulière A; Abrahams L; Hassan-Smith Z; Walker EA; Rabbitt EH; Cooper MS; Amrein K; Lavery GG; Stewart PM
    J Clin Invest; 2013 Jul; 123(7):3051-60. PubMed ID: 23722901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Corrects Cutaneous Features of Systemic Glucocorticoid Excess in Female Mice.
    Tiganescu A; Hupe M; Uchida Y; Mauro T; Elias PM; Holleran WM
    Endocrinology; 2018 Jan; 159(1):547-556. PubMed ID: 29087473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11β-hydroxysteroid dehydrogenase 1 specific inhibitor increased dermal collagen content and promotes fibroblast proliferation.
    Terao M; Tani M; Itoi S; Yoshimura T; Hamasaki T; Murota H; Katayama I
    PLoS One; 2014; 9(3):e93051. PubMed ID: 24667799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial.
    Ajjan RA; Hensor EMA; Del Galdo F; Shams K; Abbas A; Fairclough RJ; Webber L; Pegg L; Freeman A; Taylor AE; Arlt W; Morgan AW; Tahrani AA; Stewart PM; Russell DA; Tiganescu A
    Eur J Endocrinol; 2022 Feb; 186(4):441-455. PubMed ID: 35113805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization, age- and site-dependent expression, and regulation of 11β-hydroxysteroid dehydrogenase type 1 in skin.
    Tiganescu A; Walker EA; Hardy RS; Mayes AE; Stewart PM
    J Invest Dermatol; 2011 Jan; 131(1):30-6. PubMed ID: 20739946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased glucocorticoid activation during mouse skin wound healing.
    Tiganescu A; Hupe M; Uchida Y; Mauro T; Elias PM; Holleran WM
    J Endocrinol; 2014 Apr; 221(1):51-61. PubMed ID: 24464022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11β-Hydroxysteroid dehydrogenase-1 is a novel regulator of skin homeostasis and a candidate target for promoting tissue repair.
    Terao M; Murota H; Kimura A; Kato A; Ishikawa A; Igawa K; Miyoshi E; Katayama I
    PLoS One; 2011; 6(9):e25039. PubMed ID: 21949844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 Contributes to Epidermal Permeability Barrier Dysfunction in Aged Skin.
    Kim BJ; Lee NR; Lee CH; Lee YB; Choe SJ; Lee S; Hwang HJ; Kim E; Lavery GG; Shin KO; Park K; Choi EH
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycemia-activated 11β-hydroxysteroid dehydrogenase type 1 increases endoplasmic reticulum stress and skin barrier dysfunction.
    Lee YB; Hwang HJ; Kim E; Lim SH; Chung CH; Choi EH
    Sci Rep; 2023 Jun; 13(1):9206. PubMed ID: 37280272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of corticosteroids in skin physiology and therapeutic potential of an 11β-HSD1 inhibitor: A review.
    Hall L; Hart R
    Int J Dermatol; 2024 Apr; 63(4):443-454. PubMed ID: 38146184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Attenuates the Adverse Effects of Glucocorticoids on Dermal Papilla Cells.
    Lee SE; Lee EY; Kang SJ; Lee SH
    Yonsei Med J; 2017 Nov; 58(6):1204-1210. PubMed ID: 29047245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11β-HSD1 Modulates the Set Point of Brown Adipose Tissue Response to Glucocorticoids in Male Mice.
    Doig CL; Fletcher RS; Morgan SA; McCabe EL; Larner DP; Tomlinson JW; Stewart PM; Philp A; Lavery GG
    Endocrinology; 2017 Jun; 158(6):1964-1976. PubMed ID: 28368470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess.
    Morgan SA; McCabe EL; Gathercole LL; Hassan-Smith ZK; Larner DP; Bujalska IJ; Stewart PM; Tomlinson JW; Lavery GG
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):E2482-91. PubMed ID: 24889609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression, function and response to inflammatory stimuli of 11beta-hydroxysteroid dehydrogenase type 1 in human fibroblasts: a mechanism for tissue-specific regulation of inflammation.
    Hardy RS; Filer A; Cooper MS; Parsonage G; Raza K; Hardie DL; Rabbitt EH; Stewart PM; Buckley CD; Hewison M
    Arthritis Res Ther; 2006; 8(4):R108. PubMed ID: 16846535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 11β-Hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction.
    Wu L; Qi H; Zhong Y; Lv S; Yu J; Liu J; Wang L; Bi J; Kong X; Di W; Zha J; Liu F; Ding G
    Endocr J; 2013; 60(9):1047-58. PubMed ID: 23759754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
    Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH
    J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11β-hydroxysteroid dehydrogenase type 1.
    Lavery GG; Zielinska AE; Gathercole LL; Hughes B; Semjonous N; Guest P; Saqib K; Sherlock M; Reynolds G; Morgan SA; Tomlinson JW; Walker EA; Rabbitt EH; Stewart PM
    Endocrinology; 2012 Jul; 153(7):3236-48. PubMed ID: 22555437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 11β-hydroxysteroid dehydrogenase type 1 in the development of atopic dermatitis.
    Lee NR; Kim BJ; Lee CH; Lee YB; Lee S; Hwang HJ; Kim E; Kim SH; Lee MG; Lee SE; Lavery GG; Choi EH
    Sci Rep; 2020 Nov; 10(1):20237. PubMed ID: 33214595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of 11β-HSD1 Expression by Insulin in Skin: Impact for Diabetic Wound Healing.
    Brazel CB; Simon JC; Tuckermann JP; Saalbach A
    J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33260645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin 11β-hydroxysteroid dehydrogenase type 1 enzyme expression regulates burn wound healing and can be targeted to modify scar characteristics.
    Tsai KH; Shi H; Parungao RJ; Naficy S; Ding X; Ding X; Hew JJ; Wang X; Chrzanowski W; Lavery GG; Li Z; Issler-Fisher AC; Chen J; Tan Q; Maitz PK; Cooper MS; Wang Y
    Burns Trauma; 2023; 11():tkac052. PubMed ID: 36694861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.